A Nanopatterned Interdigitated Electrode Array Device for Anti migratory Cancer Drug Screening
Award amount
$225,000Program and phase
SBIR · Phase IAward year
2017Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- CURI BIO, INC.
- Proposal award date
- 2017-09-21
- Contract end date
- 2018-06-20
- UEI
- D6VABZ7RVM84
- Solicitation number
- PA16-302
- Topic code
- 102
Research abstract
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- High-Throughput NMJ Assay for Botox Potency Screening
- A cross-species preclinical platform to enhance the translation of new medicines
- High-Throughput NMJ Assay for Botox Potency Screening
- A cross-species preclinical platform to enhance the translation of new medicines
- Predictive assessment of acute and chronic cardiotoxicity using combinatorially matured hPSC-CMs
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- MiREA, a mHealth intervention to Reduce Health Disparities by Improving Equitable Access to Mandated College Students with Problematic Alcohol and Marijuana Use
- Modex, a cloud-based, centralized health economic model marketplace to reduce costs and enhance equity in cancer
- Precision screening in self-collected samples to reduce cervical cancer disparities among Latinas
- Allogeneic cell and gene therapy for neuroendocrine tumors
- Nanoparticle formulation of Mediator kinase inhibitor for the treatment of peritoneal ovarian cancer
Research funding history
16 SBIR/STTR records share this UEI (2016–2024). Reported award amounts total $11,985,726. Reported amounts are not federal obligations.
Phases: Phase I, Phase II
Agencies: Department of Health and Human Services